Fresenius Medical Care AG (FMCQF) EBIT Margin (2009 - 2026)
Fresenius Medical Care AG (FMCQF) posted quarterly EBIT Margin of 6.21% for Q1 2026, down 58.0% year-over-year from 14.77% in Q1 2025, and down 47.04% quarter-over-quarter from 11.72% in Q4 2025.
Fresenius Medical Care AG (FMCQF) EBIT Margin (2009 - 2026) Analysis & Trends
Fresenius Medical Care AG's EBIT Margin history runs 18 years deep, the most recent figure standing at 6.21% for Q1 2026.
- In Q1 2026, EBIT Margin fell 58.0% year-over-year to 6.21%; the TTM figure through Mar 2026 stood at 9.2% (up 160.0% YoY), while the FY2025 annual figure was 9.31%, up 211.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 6.21%, down from 11.72% in the prior quarter.
- The five-year high for EBIT Margin was 46.03% in Q4 2022, with the low at 5.09% in Q4 2024.
- The 5-year median for EBIT Margin is 8.91% (2024), against an average of 12.27%.
- The sharpest annual moves came in 2022 and 2024: EBIT Margin surged 4349 bps in 2022, then sank 3065 bps in 2024.
- Fresenius Medical Care AG's EBIT Margin stood at 46.03% in 2022, then declined by 22 bps to 35.75% in 2023, then slumped by 86 bps to 5.09% in 2024, then soared by 130 bps to 11.72% in 2025, then slumped by 47 bps to 6.21% in 2026.
- Business Quant data shows FMCQF's EBIT Margin at 6.21% in Q1 2026, 11.72% in Q4 2025, and 9.75% in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.58% |
| Mar 31, 2026 | 6.21% |
| Dec 31, 2025 | 11.72% |
| Sep 30, 2025 | 9.75% |
| Jun 30, 2025 | 8.87% |
| Mar 31, 2025 | 6.79% |
| Dec 31, 2024 | 5.09% |
| Sep 30, 2024 | 9.72% |
| Jun 30, 2024 | 8.91% |
| Mar 31, 2024 | 8.53% |
| Dec 31, 2023 | 35.75% |
| Sep 30, 2023 | 6.56% |
| Jun 30, 2023 | 9.32% |
| Mar 31, 2023 | 7.03% |
| Dec 31, 2022 | 46.03% |
| Sep 30, 2022 | 11.55% |
| Jun 30, 2022 | 9.02% |
| Mar 31, 2022 | 7.65% |
| Dec 31, 2021 | 2.55% |
| Sep 30, 2021 | 14.30% |